🏛️ Verified NIH Record • Updated 2026-07-13
Endocardial Mapping With the CoreMap EP Mapping System (NCT06529978)
Endocardial Mapping With the CoreMap Electrophysiology Mapping System for Persistent Atrial Fibrillation Protocol
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: CoreMap Inc.
🩺 Plain-English Summary (8th-Grade Level)
This is a global, multi-site, prospective, feasibility study.
Who can join: Review the eligibility criteria below.
Location: NCH Downtown Baker Hospital — Naples, Florida
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- NCH Downtown Baker Hospital — Naples, Florida
- University of Vermont Medical Center — Burlington, Vermont
- Virginia Commonwealth University (VCU) — Richmond, Virginia
- Na Homolce Hospital — Praha Klanovice,
📞 Contact the Study Coordinator
Phone: (617) 872-3908
Email: jfoster@coremapmedical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Persistent Atrial Fibrillation
- Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Jonesboro, Arkansas
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
- SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
- Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
- STOP Persistent AF PAS — Hartford, Connecticut
- REPRESENT-PF Registry — New York, New York
Explore by condition: All Persistent Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.